Second Opinions for Breast Cancer Patients: Minimal Impact on Treatment Timelines
核心洞察
Patients seeking second opinions for breast cancer (搜索) experience a median 41.5-day timeline from biopsy to treatment, compared to 31 days for those staying within their original institution.
Despite the additional time, second opinion timelines still fall well within the Commission on Cancer (搜索) guidelines of 60 days, providing reassurance to patients concerned about treatment delays.
Researchers found that second opinion patients required additional imaging and biopsies more frequently (90.3% vs 68.1%), but the time from surgical consultation to treatment remained similar between both groups.
A new study from the Cleveland Clinic reveals that breast cancer (搜索) patients who seek second opinions experience only modest delays in treatment initiation, with timelines still well within established guidelines.
The research, presented at the annual meeting of the American Society of Breast Surgeons (搜索) held from April 30 to May 4 in Las Vegas, compared treatment timelines between patients who sought external second opinions and those who remained within their diagnosing institution.
Minimal Impact on Critical Treatment Timelines
Dr. Pooja Varman (搜索) and colleagues from the Cleveland Clinic Foundation conducted a retrospective cohort study examining 226 patients with newly diagnosed stage 0 to III breast cancer (搜索) treated between January and July 2024. The study compared 113 patients who sought second opinions (external) with 113 patients diagnosed and treated within the same institution (internal).
The results showed that while seeking a second opinion did extend the overall timeline, the impact was not clinically significant. The median time from biopsy to first treatment was 35 days overall, with external patients experiencing 41.5 days compared to 31 days for internal patients.
"Breast cancer (搜索) is a life-altering experience," Dr. Varman stated. "For patients, exploring all treatment options and finding a physician and clinical team they are comfortable with is crucial."
Time to Treatment Within Guidelines
Importantly, the researchers found that the median time from first surgical oncology appointment to treatment initiation was nearly identical between groups—20 days for external patients versus 21 days for internal patients.
These timelines fall well within the Commission on Cancer (搜索) (CoC) guidelines, which recommend treatment initiation within 60 days of diagnosis. This finding should reassure patients who worry that seeking additional medical opinions might compromise their care.
Additional Workup Requirements
The study identified that patients seeking second opinions required additional diagnostic procedures more frequently. External patients needed additional imaging and biopsies at significantly higher rates (90.3%) compared to internal patients (68.1%).
This additional workup correlated with increased median time to treatment. Similarly, consultations with plastic surgeons were associated with longer timelines to treatment initiation.
Clinical Implications for Patient Decision-Making
Dr. Varman emphasized that patients seek second opinions for various reasons, and the emotional component of treatment decisions should not be underestimated.
"Cancer treatment is a physically and emotionally difficult journey, and feeling comfortable with the path chosen is extremely important," she noted. "This study should reassure patients that a second opinion need not impact all-important timeliness of care."
Study Methodology and Limitations
The retrospective cohort design included patients with stage 0 to III breast cancer (搜索) treated at a single cancer center. All patients received their first treatment between January and July 2024, with equal distribution between those diagnosed externally and internally.
As with all research presented at medical meetings, these findings should be considered preliminary until published in a peer-reviewed journal.
Patient Considerations
For newly diagnosed breast cancer (搜索) patients, these findings provide valuable context for decision-making. While seeking a second opinion does add some time to the treatment pathway, the delay is modest and unlikely to affect clinical outcomes.
The research suggests that patients should prioritize finding medical teams they trust and treatment plans they feel confident in, rather than rushing into treatment due to concerns about delays from seeking additional opinions.
"Cleveland Clinic internal patients had an even shorter time to treatment, but external patients' average time to treatment was still well within guidelines," Dr. Varman concluded in the study presentation.